Your session is about to expire
← Back to Search
Behavioral Intervention
Acceptance-Based Coping Skills for Type 2 Diabetes (ABaCo Trial)
N/A
Recruiting
Led By Kathryn Kanzler, PsyD ABPP
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18-70
Diagnosis of Type 2 Diabetes (T2DM)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 6, 10, 24 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if community health workers can effectively deliver an educational program for Hispanic/Latino patients with type 2 diabetes. They want to know if this program helps manage blood sugar levels and
Who is the study for?
This trial is for Hispanic/Latino patients with type 2 diabetes. Participants will engage in a program delivered by community health workers over the phone, aimed at improving blood sugar management and quality of life. They must be willing to provide blood samples, answer questionnaires, and commit to weekly calls plus a follow-up.
What is being tested?
The ABaCo (Acceptance Based Coping) program is being tested for its effectiveness when taught by promotores via phone calls. The study checks if this method helps patients manage their diabetes better and enhances their overall well-being.
What are the potential side effects?
Since ABaCo is an educational intervention focusing on coping skills rather than medication or medical procedures, there are no direct physical side effects expected from participating in this trial.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 70 years old.
Select...
I have been diagnosed with Type 2 Diabetes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0, 6, 10, 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 6, 10, 24 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Average blood glucose management (HbA1c)
Quality of life: Patient Reported Outcomes Measurement Information System Global-10
Secondary study objectives
Diabetes Acceptance: Acceptance & Action Diabetes Questionnaire (AADQ)
Diabetes Acceptance: Diabetes Acceptance Scale (DAS)
Diabetes Distress: Diabetes Distress Scale
+2 moreOther study objectives
Acceptability: Interviews
Acceptability: Ratings
Feasibility: Recruitment
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Acceptance Based Coping (ABaCo) Skills TrainingExperimental Treatment1 Intervention
Participant-patients will receive care as usual in the Nosotros Promotores program at University Health Robert B Green Campus Family Health Center, including standardized procedures (e.g., home visits, phone calls and in-clinic visits), along with this protocol - individual telephone-delivered ABaCo skills intervention delivered by one Promotor/a for 10 weeks (6 weeks plus booster at 10 weeks).
Find a Location
Who is running the clinical trial?
Baylor College of MedicineLead Sponsor
1,022 Previous Clinical Trials
6,029,297 Total Patients Enrolled
The University of Texas Health Science Center at San AntonioOTHER
474 Previous Clinical Trials
92,145 Total Patients Enrolled
Kathryn Kanzler, PsyD ABPPPrincipal InvestigatorBaylor College of Medicine; UT Health San Antonio
Share this study with friends
Copy Link
Messenger